Management of Patient with ALT 12x Normal
A patient with ALT 12 times the upper limit of normal requires immediate ICU-level monitoring, urgent diagnostic workup to identify the etiology, and prompt initiation of N-acetylcysteine (NAC) regardless of whether acetaminophen toxicity is confirmed, as this represents acute liver failure (ALF) with significant mortality risk. 1, 2
Immediate Actions
1. Admission and Monitoring
- Admit to ICU immediately for frequent monitoring 1
- Contact a liver transplant center early in the evaluation process 1
- Monitor for signs of hepatic encephalopathy, coagulopathy, and hemodynamic instability
2. Urgent Diagnostic Workup
Essential initial tests:
- Acetaminophen level (even without history of ingestion - very high ALT >3,500 IU/L is highly correlated with acetaminophen poisoning) 1
- Viral hepatitis panel: Hepatitis A IgM, Hepatitis B surface antigen and core antibody, Hepatitis C antibody, Hepatitis E (especially if immunocompromised) 2, 3
- Autoimmune markers: ANA, anti-smooth muscle antibody, immunoglobulins 2
- Abdominal Doppler ultrasound to assess for:
- Vascular patency (hepatic veins, portal vein - rule out Budd-Chiari)
- Signs of chronic liver disease
- Biliary obstruction 2
- Echocardiography if ischemic hepatitis suspected (AST > ALT, elderly, cardiac history, shock) 2
- Pregnancy test in women of childbearing age
- Toxicology screen including mushroom ingestion history 1
Calculate R value to determine injury pattern: (ALT/ALT ULN)/(ALP/ALP ULN)
- R ≥5: Hepatocellular injury (most likely with 12x ALT elevation)
- R ≤2: Cholestatic injury
- R 2-5: Mixed pattern 4
Medication Management
N-Acetylcysteine (NAC) - Start Immediately
For known/suspected acetaminophen toxicity:
- Oral route (if patient can tolerate): 140 mg/kg loading dose, then 70 mg/kg every 4 hours for 17 doses 1
- IV route (preferred in ALF due to altered mental status or GI bleeding):
- Loading: 150 mg/kg in 5% dextrose over 15 minutes
- Maintenance: 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours 1
For non-acetaminophen ALF:
- Initiate NAC therapy regardless of etiology to improve transplant-free survival (64% vs 26%) and overall survival (76% vs 59%) 2
- Most beneficial when started early (grades I-II encephalopathy) 2
- Side effects: nausea, vomiting, rare urticaria or bronchospasm (treat with antihistamines, epinephrine if needed) 1, 2
If Acetaminophen Ingestion Within 4 Hours
- Give activated charcoal 1 g/kg orally just prior to starting NAC (does not reduce NAC effectiveness) 1
Etiology-Specific Treatments
Mushroom poisoning (Amanita phalloides):
- Penicillin G 300,000-1 million units/kg/day IV 1
- Silibinin (silymarin) if available 1
- Gastric lavage and activated charcoal if within hours of ingestion 1
Autoimmune hepatitis:
- Consider corticosteroids only after confirmation with liver biopsy 3
Hepatitis B with decompensation:
- Lamivudine or adefovir (coordinate with transplant center) 5
Medications to STOP Immediately
- All potentially hepatotoxic drugs including:
- Statins
- Antimicrobials (especially antituberculous drugs)
- Antiepileptics
- Herbal supplements
- Any drug started within past 6 months 2
Monitoring Parameters
- Mental status every 1-2 hours (grade encephalopathy)
- INR/PT every 12-24 hours
- Glucose every 4-6 hours (risk of hypoglycemia)
- Creatinine daily (hepatorenal syndrome risk)
- ALT, AST, bilirubin, alkaline phosphatase daily
- Arterial ammonia if encephalopathy develops
Prognostic Indicators
Poor prognosis (transplant-free survival <25%) associated with: 2
- Non-acetaminophen drug-induced liver injury
- Hepatitis B
- Autoimmune hepatitis
- Wilson's disease
- Budd-Chiari syndrome
Better prognosis (transplant-free survival ~50%) with: 2
- Acetaminophen toxicity
- Hepatitis A
- Ischemic hepatitis
- Pregnancy-related ALF
Critical Pitfalls to Avoid
- Do NOT delay NAC while waiting for acetaminophen levels - start immediately 2
- Do NOT assume normal acetaminophen level rules out toxicity - ingestion may be remote or unintentional over several days 1
- Do NOT use interferon in decompensated cirrhosis - it is contraindicated 5
- Do NOT overlook ischemic hepatitis - check for cardiac/circulatory failure, especially if AST > ALT 2
- Do NOT forget to inquire about mushroom ingestion - even if remote history 1
Transplant Evaluation Criteria
Initiate transplant evaluation if patient develops: